ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $100,000 | -54.3% | 107,530 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $219,000 | -37.4% | 107,530 | -11.9% | 0.00% | -50.0% |
| Q3 2019 | $350,000 | -45.6% | 122,030 | +45.6% | 0.00% | -60.0% |
| Q2 2019 | $643,000 | +39.8% | 83,786 | +142.3% | 0.01% | +25.0% |
| Q1 2019 | $460,000 | -14.7% | 34,586 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $539,000 | +0.6% | 34,586 | +26.8% | 0.01% | +25.0% |
| Q3 2018 | $536,000 | -38.7% | 27,286 | -10.5% | 0.00% | -33.3% |
| Q2 2018 | $875,000 | -57.7% | 30,495 | -65.1% | 0.01% | -57.1% |
| Q1 2018 | $2,069,000 | +58.9% | 87,495 | +44.2% | 0.01% | +75.0% |
| Q4 2017 | $1,302,000 | +86.5% | 60,695 | +105.8% | 0.01% | +166.7% |
| Q3 2017 | $698,000 | +47.6% | 29,495 | +22.9% | 0.00% | -25.0% |
| Q2 2017 | $473,000 | -32.6% | 24,005 | -28.1% | 0.00% | -33.3% |
| Q1 2017 | $702,000 | +16.0% | 33,405 | +3.7% | 0.01% | 0.0% |
| Q4 2016 | $605,000 | -10.0% | 32,205 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $672,000 | -18.1% | 32,205 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $821,000 | -3.6% | 32,205 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $852,000 | -34.5% | 32,205 | +5.9% | 0.01% | -18.2% |
| Q4 2015 | $1,301,000 | +4.2% | 30,405 | -35.5% | 0.01% | 0.0% |
| Q3 2015 | $1,249,000 | -43.3% | 47,105 | -28.7% | 0.01% | -31.2% |
| Q2 2015 | $2,203,000 | -17.8% | 66,105 | -17.9% | 0.02% | -20.0% |
| Q1 2015 | $2,679,000 | -16.6% | 80,505 | +2.4% | 0.02% | -4.8% |
| Q4 2014 | $3,213,000 | +20.7% | 78,607 | 0.0% | 0.02% | +23.5% |
| Q3 2014 | $2,663,000 | -13.6% | 78,607 | -14.0% | 0.02% | -10.5% |
| Q2 2014 | $3,081,000 | -2.4% | 91,407 | +9.7% | 0.02% | -5.0% |
| Q1 2014 | $3,158,000 | +7.6% | 83,300 | -17.1% | 0.02% | +11.1% |
| Q4 2013 | $2,935,000 | -12.8% | 100,500 | +2.3% | 0.02% | -14.3% |
| Q3 2013 | $3,366,000 | +33.0% | 98,200 | +28.0% | 0.02% | +5.0% |
| Q2 2013 | $2,530,000 | – | 76,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|